ascopost.com

Analisi sito web ascopost.com

TAP Homepage - The ASCO Post

 Generato il Marzo 05 2026 11:22 AM

Statistiche non aggiornate? AGGIORNA !

Il punteggio e 45/100

SEO Content

Title

TAP Homepage - The ASCO Post

Lunghezza : 28

Perfetto, il tuo title contiene tra 10 e 70 caratteri.

Description

Lunghezza : 0

Molto male. Non abbiamo trovato meta description nella tua pagina. Usa questo generatore online gratuito di meta tags per creare la descrizione.

Keywords

Molto male. Non abbiamo trovato meta keywords nella tua pagina. Usa questo generatore gratuito online di meta tags per creare keywords.

Og Meta Properties

Questa pagina non sfrutta i vantaggi Og Properties. Questi tags consentono ai social crawler di strutturare meglio la tua pagina. Use questo generatore gratuito di og properties per crearli.

Headings

H1 H2 H3 H4 H5 H6
1 1 16 5 10 0
  • [H1] More Top Stories
  • [H2] Sponsored Content
  • [H3] ‘Prostate Screening Saved My Life’—Is That Really True In Most Cases?
  • [H3] SABCS 2025: Top Picks From a Breast Cancer Specialist
  • [H3] How the Outlook on Fertility Preservation for Patients With Cancer Is Improving
  • [H3] Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC
  • [H3] Advanced Nonsquamous NSCLC: FDA Grants Accelerated Approval to Zongertinib
  • [H3] SPONSORED BY JOHNSON & JOHNSON
  • [H3] Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease
  • [H3] I Used AI to Supplement My Oncology Care—It Reshaped My Treatment Plan
  • [H3] Colorectal Cancer: ACS Report Shows Increasing Incidence, Mortality Rates in Younger Adults
  • [H3] Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel
  • [H3] ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC
  • [H3] Leader in Global Cancer Care, Paul E. Goss, MD, PhD, FRCPC, FRCP Dies at 70
  • [H3] Research Suggests AI Pathology Models May Take Unreliable 'Shortcuts' to Identify Cancer Biomarkers
  • [H3] Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin
  • [H3] Introducing ASCO AI in Oncology
  • [H3] Lisocabtagene Maraleucel in Relapsed or Refractory MZL
  • [H4] Stephen Lam Chan, MD, FRCP, MRCP, on HCC: Pembrolizumab After Resection or Local Ablation
  • [H4] Matthew Strickland, MD, on Locally Advanced Gastric/GEJ Cancer: Tislelizumab Plus Chemoradiotherapy
  • [H4] Dina Ioffe, MD, on Disparities in HCC: Do They Affect Systemic Care?
  • [H4] Daniela Molena, MD, on Surgical Journey in the MATTERHORN Trial
  • [H4] Elena Elimova, MD, on HER2-Positive Gastroesophageal Cancer: Zanidatamab Plus Chemotherapy
  • [H5] Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes
  • [H5] CD123-Targeting ADC Shows Activity in AML and BPDCN
  • [H5] Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
  • [H5] Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
  • [H5] Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers
  • [H5] Charles Bennett and colleagues: The Inflation Reduction Act and Ibrutinib
  • [H5] Derek Raghavan: How I Discuss the Current Political Chaos When Patients Ask Health-Related Questions About It
  • [H5] Narjust Florez and Coral Olazagasti: Silence Is Complicity
  • [H5] Robert Peter Gale: Therapy With a TKI for EGFR-Variant Lung Adenocarcinoma: Lessons From CML?
  • [H5] Raj Mohan on Kindness, Mercy, Empathy, Compassion: Are They Relevant in the Era of Robotics and AI?

Images

Abbiamo trovato 25 immagini in questa pagina web.

23 attributi alt sono vuoti o mancanti. Aggiungi testo alternativo in modo tale che i motori di ricerca possano comprendere meglio il contenuto delle tue immagini.

Text/HTML Ratio

Ratio : 10%

Il rapporto testo/codice HTML di questa pagina e inferiore a 15 percento, questo significa che il tuo sito web necessita probabilmente di molto piu contenuto.

Flash

Perfetto, non e stato rilevato contenuto Flash in questa pagina.

Iframe

Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.

URL Rewrite

Buono. I tuoi links appaiono friendly!

Underscores in the URLs

Perfetto! Non sono stati rilevati underscores nei tuoi URLs.

In-page links

Abbiamo trovato un totale di 74 links inclusi 0 link(s) a files

Anchor Type Juice
- Interno Passing Juice
About The ASCO Post Interno Passing Juice
Editorial Board Interno Passing Juice
Rights and Permissions Interno Passing Juice
Contact Interno Passing Juice
Subscribe Interno Passing Juice
FDA Update Interno Passing Juice
Journal Spotlight Interno Passing Juice
Expert's Corner Interno Passing Juice
In the Clinic Interno Passing Juice
View By Issue Interno Passing Juice
View All Interno Passing Juice
2026 ASCO GU Interno Passing Juice
2026 ASCO GI Interno Passing Juice
SUO 2025 Interno Passing Juice
SABCS 2025 Interno Passing Juice
ASH 2025 Interno Passing Juice
Calendar Interno Passing Juice
View All Interno Passing Juice
AI in Oncology Interno Passing Juice
Breast Cancer Interno Passing Juice
Lung Cancer Interno Passing Juice
Prostate Cancer Interno Passing Juice
Lymphoma Interno Passing Juice
Cardio-oncology Interno Passing Juice
View All Interno Passing Juice
Charles Bennett and colleagues: The Inflation Reduction Act and Ibrutinib Interno Passing Juice
Derek Raghavan: How I Discuss the Current Political Chaos When Patients Ask Health-Related Questions About It Interno Passing Juice
Narjust Florez and Coral Olazagasti: Silence Is Complicity Interno Passing Juice
Robert Peter Gale: Therapy With a TKI for EGFR-Variant Lung Adenocarcinoma: Lessons From CML? Interno Passing Juice
Raj Mohan on Kindness, Mercy, Empathy, Compassion: Are They Relevant in the Era of Robotics and AI? Interno Passing Juice
Newsreels Interno Passing Juice
Video Roundtables Interno Passing Juice
Podcasts Interno Passing Juice
‘Prostate Screening Saved My Life’—Is That Really True In Most Cases? Interno Passing Juice
SABCS 2025: Top Picks From a Breast Cancer Specialist Interno Passing Juice
Issues in Oncology Interno Passing Juice
How the Outlook on Fertility Preservation for Patients With Cancer Is Improving Interno Passing Juice
Bladder Cancer Interno Passing Juice
Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC Interno Passing Juice
Advanced Nonsquamous NSCLC: FDA Grants Accelerated Approval to Zongertinib Interno Passing Juice
Hepatobiliary Cancer Interno Passing Juice
Stephen Lam Chan, MD, FRCP, MRCP, on HCC: Pembrolizumab After Resection or Local Ablation Interno Passing Juice
Gastroesophageal Cancer Interno Passing Juice
Gastrointestinal Cancer Interno Passing Juice
Matthew Strickland, MD, on Locally Advanced Gastric/GEJ Cancer: Tislelizumab Plus Chemoradiotherapy Interno Passing Juice
Dina Ioffe, MD, on Disparities in HCC: Do They Affect Systemic Care? Interno Passing Juice
Daniela Molena, MD, on Surgical Journey in the MATTERHORN Trial Interno Passing Juice
Elena Elimova, MD, on HER2-Positive Gastroesophageal Cancer: Zanidatamab Plus Chemotherapy Interno Passing Juice
Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes Interno Passing Juice
CD123-Targeting ADC Shows Activity in AML and BPDCN Interno Passing Juice
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds Interno Passing Juice
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence Interno Passing Juice
Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers Interno Passing Juice
Hematologic Malignancies Interno Passing Juice
Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease Interno Passing Juice
I Used AI to Supplement My Oncology Care—It Reshaped My Treatment Plan Interno Passing Juice
Colorectal Cancer: ACS Report Shows Increasing Incidence, Mortality Rates in Younger Adults Interno Passing Juice
Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel Interno Passing Juice
ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC Interno Passing Juice
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, FRCPC, FRCP Dies at 70 Interno Passing Juice
Leukemia Interno Passing Juice
Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin Interno Passing Juice
Introducing ASCO AI in Oncology Interno Passing Juice
Lisocabtagene Maraleucel in Relapsed or Refractory MZL Interno Passing Juice
Social Media Hub Externo Passing Juice
Bots not welcome here Interno noFollow
Editorial Board Interno Passing Juice
Advertising Interno Passing Juice
Disclosures Interno Passing Juice
Contact Interno Passing Juice
Privacy Policy Externo Passing Juice
Disclaimer Interno Passing Juice
ASCO.org Externo Passing Juice

SEO Keywords

Keywords Cloud

advertisement cancer patients lung screening oncology fertility prostate therapy psa

Consistenza Keywords

Keyword Contenuto Title Keywords Description Headings
cancer 13
oncology 6
patients 6
advertisement 4
fertility 3

Usabilita

Url

Dominio : ascopost.com

Lunghezza : 12

Favicon

Grande, il tuo sito usa una favicon.

Stampabilita

Non abbiamo riscontrato codice CSS Print-Friendly.

Lingua

Buono. La tua lingua dichiarata en.

Dublin Core

Questa pagina non sfrutta i vantaggi di Dublin Core.

Documento

Doctype

HTML 5

Encoding

Perfetto. Hai dichiarato che il tuo charset e UTF-8.

Validita W3C

Errori : 0

Avvisi : 0

Email Privacy

Grande. Nessun indirizzo mail e stato trovato in plain text!

Deprecated HTML

Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.

Suggerimenti per velocizzare

Eccellente, il tuo sito web non utilizza nested tables.
Molto male, il tuo sito web utilizza stili CSS inline.
Molto male, il tuo sito web ha troppi file CSS files (piu di 4).
Molto male, il tuo sito web ha troppi file JS (piu di 6).
Perfetto, il vostro sito si avvale di gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Ottimizzazione

XML Sitemap

Grande, il vostro sito ha una sitemap XML.

http://www.ascopost.com/sitemap/

Robots.txt

https://ascopost.com/robots.txt

Grande, il vostro sito ha un file robots.txt.

Analytics

Grande, il vostro sito ha uno strumento di analisi dei dati.

   Google Analytics

PageSpeed Insights

Dispositivo
Categorie

Free SEO Testing Tool

Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web